C4urself the 1st Ammendment.
Don't assume that i don't know, and i wont assume, that you have no idea.
Recent NUWE News
- Nuwellis Announces Reverse Stock Split • GlobeNewswire Inc. • 06/26/2024 12:45:00 PM
- Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™ • GlobeNewswire Inc. • 06/25/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 01:15:27 PM
- Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase • GlobeNewswire Inc. • 06/06/2024 01:00:00 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/29/2024 03:54:05 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/17/2024 09:22:31 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 05/17/2024 09:20:53 PM
- Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida • GlobeNewswire Inc. • 05/14/2024 01:00:00 PM
- Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy • GlobeNewswire Inc. • 05/09/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 09:28:54 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 05/08/2024 09:26:11 PM
- Nuwellis, Inc. Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
- Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology • GlobeNewswire Inc. • 05/02/2024 01:00:00 PM
- Nuwellis Announces Closing of $2.7 Million Public Offering • GlobeNewswire Inc. • 04/30/2024 10:09:12 PM
- Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/30/2024 08:41:07 PM
- Nuwellis Announces Pricing of $2.7 Million Public Offering • GlobeNewswire Inc. • 04/26/2024 01:17:51 PM
- Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health • GlobeNewswire Inc. • 04/09/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 09:08:24 PM
- Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference • GlobeNewswire Inc. • 03/07/2024 02:08:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 05:02:05 PM
- Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- U.S. Futures Dip, Crude Oil Fluctuates • IH Market News • 03/05/2024 11:05:54 AM
- Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 • GlobeNewswire Inc. • 02/27/2024 02:00:00 PM
- Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™ • GlobeNewswire Inc. • 02/22/2024 12:58:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM